ELF1 is associated with systemic lupus erythematosus in Asian populations

Human Molecular Genetics

Volumn 20, Issue 3, 2011, Pages 601-607

  Yang, Jing ^a   Yang, Wanling ^a   Hirankarn, Nattiya ^b   Ye, Dong Qing ^c   Zhang, Yan ^a   Pan, Hai Feng ^c   Mok, Chi Chiu ^d   Chan, Tak Mao ^a   Sing Wong, Raymond Woon ^a   Mok, Mo Yin ^a   Lee, Ka Wing ^e   Wong, Sik Nin ^d   Ho Leung, Alexander Moon ^f   Li, Xiang Pei ^g   Avihingsanon, Yingyos ^b   Rianthavorn, Pornpimol ^b   Deekajorndej, Thavatchai ^b   Suphapeetiporn, Kanya ^b   Shotelersuk, Vorasuk ^b   Baum, Larry ^h   Kwan, Patrick ^h   Lee, Tsz Leung ^a   Kung Ho, Marco Hok ^a   Wah Lee, Pamela Pui ^a   Sang Wong, Wilfred Hing ^a   Zeng, Shuai ^a   Zhang, Jing ^a   Wong, Chun Ming ^a   Lin Ng, Irene Oi ^a   Garcia Barceló, Maria Mercè ^a   Cherny, Stacey S ^a   Tam, Paul Kwong Hang ^a   Sham, Pak Chung ^a   Lau, Chak Sing ^a   Lau, Yu Lung ^a   more..

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c ANHUI MEDICAL UNIVERSITY   (China)

^d TUEN MUN HOSPITAL   (Hong Kong)

^e PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

^f QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^g ANHUI PROVINCIAL HOSPITAL   (China)

^h CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR ELF 1;

ARTICLE; ASIAN; AUTOIMMUNE DISEASE; CELL FUNCTION; CELL MATURATION; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; EXON; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HERITABILITY; HONG KONG; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN FUNCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TRANSCRIPTION REGULATION;

EID: 78651086505     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddq474     Document Type: Article

References (55)

1. Mok, C.C. and Lau, C.S. (2003) Lupus in Hong Kong Chinese. Lupus, 12, 717-722.
2. Wong, S.N., Tse, K.C., Lee, T.L., Lee, K.W., Chim, S., Lee, K.P., Wai-Po, C.R., Chan, W., Fong, K.W., Hui, J. et al. (2006) Lupus nephritis in Chinese children-a territory-wide cohort study in Hong Kong. Pediatr. Nephrol., 21, 1104-1112.
3. Arnett, F.C. and Shulman, L.E. (1976) Studies in familial systemic lupus erythematosus. Medicine (Baltimore), 55, 313-322.
4. Ramos-Niembro, F. and Alarcon-Segovia, D. (1978) Familial aspects of mixed connective tissue disease (MCTD). I. Occurrence of systemic lupus erythematosus in another member in two families and aggregation of MCTD in another family. J. Rheumatol., 5, 433-440.
5. Sestak, A.L., Shaver, T.S., Moser, K.L., Neas, B.R. and Harley, J.B. (1999) Familial aggregation of lupus and autoimmunity in an unusual multiplex pedigree. J. Rheumatol., 26, 1495-1499.
6. Graham, R.R., Kozyrev, S.V., Baechler, E.C., Reddy, M.V., Plenge, R.M., Bauer, J.W., Ortmann, W.A., Koeuth, T., Gonzalez Escribano, M.F., Pons-Estel, B. et al. (2006) A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat. Genet., 38, 550-555.
7. Sigurdsson, S., Goring, H.H., Kristjansdottir, G., Milani, L., Nordmark, G., Sandling, J.K., Eloranta, M.L., Feng, D., Sangster-Guity, N., Gunnarsson, I. et al. (2008) Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus. Hum. Mol. Genet., 17, 872-881.
8. Graham, R.R., Kyogoku, C., Sigurdsson, S., Vlasova, I.A., Davies, L.R., Baechler, E.C., Plenge, R.M., Koeuth, T., Ortmann, W.A., Hom, G. et al. (2007) Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc. Natl Acad. Sci. USA, 104, 6758-6763.
9. Kozyrev, S.V., Lewen, S., Reddy, P.M., Pons-Estel, B., Witte, T., Junker, P., Laustrup, H., Gutierrez, C., Suarez, A., Francisca Gonzalez-Escribano, M. et al. (2007) Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus. Arthritis Rheum., 56, 1234-1241.
10. Siu, H.O., Yang, W., Lau, C.S., Chan, T.M., Wong, R.W., Wong, W.H., Lau, Y.L. and Alarcon-Riquelme, M.E. (2008) Association of a haplotype of IRF5 gene with systemic lupus erythematosus in Chinese. J. Rheumatol., 35, 360-362.
11. Kawasaki, A., Kyogoku, C., Ohashi, J., Miyashita, R., Hikami, K., Kusaoi, M., Tokunaga, K., Takasaki, Y., Hashimoto, H., Behrens, T.W. et al. (2008) Association of IRF5 polymorphisms with systemic lupus erythematosus in a Japanese population: support for a crucial role of intron 1 polymorphisms. Arthritis Rheum., 58, 826-834.
12. Shin, H.D., Sung, Y.K., Choi, C.B., Lee, S.O., Lee, H.W. and Bae, S.C. (2007) Replication of the genetic effects of IFN regulatory factor 5 (IRF5) on systemic lupus erythematosus in a Korean population. Arthritis Res. Ther., 9, R32.
13. Remmers, E.F., Plenge, R.M., Lee, A.T., Graham, R.R., Hom, G., Behrens, T.W., de Bakker, P.I., Le, J.M., Lee, H.S., Batliwalla, F. et al. (2007) STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N. Engl. J. Med., 357, 977-986.
14. Yang, W., Ng, P., Zhao, M., Hirankarn, N., Lau, C.S., Mok, C.C., Chan, T.M., Wong, R.W., Lee, K.W., Mok, M.Y. et al. (2009) Population differences in SLE susceptibility genes: STAT4 and BLK, but not PXK, are associated with systemic lupus erythematosus in Hong Kong Chinese. Genes Immun., 10, 219-226.
15. Kobayashi, S., Ikari, K., Kaneko, H., Kochi, Y., Yamamoto, K., Shimane, K., Nakamura, Y., Toyama, Y., Mochizuki, T., Tsukahara, S. et al. (2008) Association of STAT4 with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Japanese population. Arthritis Rheum., 58, 1940-1946.
16. Palomino-Morales, R.J., Rojas-Villarraga, A., Gonzalez, C.I., Ramirez, G., Anaya, J.M. and Martin, J. (2008) STAT4 but not TRAF1/C5 variants influence the risk of developing rheumatoid arthritis and systemic lupus erythematosus in Colombians. Genes Immun., 9, 379-382.
17. Kawasaki, A., Ito, I., Hikami, K., Ohashi, J., Hayashi, T., Goto, D., Matsumoto, I., Ito, S., Tsutsumi, A., Koga, M. et al. (2008) Role of STAT4 polymorphisms in systemic lupus erythematosus in a Japanese population: a case-control association study of the STAT1-STAT4 region. Arthritis Res. Ther., 10, R113.
18. Yang, W., Zhao, M., Hirankarn, N., Lau, C.S., Mok, C.C., Chan, T.M., Wong, R.W., Lee, K.W., Mok, M.Y., Wong, S.N. et al. (2009) ITGAM is associated with disease susceptibility and renal nephritis of systemic lupus erythematosus in Hong Kong Chinese and Thai. Hum. Mol. Genet., 18, 2063-2070.
19. Yang, W., Shen, N., Ye, D.Q., Liu, Q., Zhang, Y., Qian, X.X., Hirankarn, N., Ying, D., Pan, H.F., Mok, C.C. et al. (2010) Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. PLoS Genet., 6, e1000841.
20. Han, J.W., Zheng, H.F., Cui, Y., Sun, L.D., Ye, D.Q., Hu, Z., Xu, J.H., Cai, Z.M., Huang, W., Zhao, G.P. et al. (2009) Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat. Genet., 41, 1234-1237.
21. Harley, J.B., Alarcon-Riquelme, M.E., Criswell, L.A., Jacob, C.O., Kimberly, R.P., Moser, K.L., Tsao, B.P., Vyse, T.J., Langefeld, C.D., Nath, S.K. et al. (2008) Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat. Genet., 40, 204-210.
22. Gateva, V., Sandling, J.K., Hom, G., Taylor, K.E., Chung, S.A., Sun, X., Ortmann, W., Kosoy, R., Ferreira, R.C., Nordmark, G. et al. (2009) A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat. Genet., 41, 1228-1233.
23. Kim, I., Kim, Y.J., Kim, K., Kang, C., Choi, C.B., Sung, Y.K., Lee, H.S. and Bae, S.C. (2009) Genetic studies of systemic lupus erythematosus in Asia: where are we now?. Genes Immun., 10, 421-432.
24. Gallant, S. and Gilkeson, G. (2006) ETS transcription factors and regulation of immunity. Arch. Immunol. Ther. Exp. (Warsz), 54, 149-163.
25. Wang, C.Y., Petryniak, B., Thompson, C.B., Kaelin, W.G. and Leiden, J.M. (1993) Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein. Science, 260, 1330-1335.
26. Thompson, C.B., Wang, C.Y., Ho, I.C., Bohjanen, P.R., Petryniak, B., June, C.H., Miesfeldt, S., Zhang, L., Nabel, G.J., Karpinski, B. et al. (1992) Cis-acting sequences required for inducible interleukin-2 enhancer function bind a novel Ets-related protein, Elf-1. Mol. Cell Biol., 12, 1043-1053.
27. Wang, Q.H., Nishiyama, C., Nakano, N., Shimokawa, N., Hara, M., Kanada, S., Ogawa, H. and Okumura, K. (2008) Suppressive effect of Elf-1 on FcepsilonRI alpha-chain expression in primary mast cells. Immunogenetics, 60, 557-563.
28. Price, A.L., Patterson, N.J., Plenge, R.M., Weinblatt, M.E., Shadick, N.A. and Reich, D. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet., 38, 904-909.
29. Dixon, A.L., Liang, L., Moffatt, M.F., Chen, W., Heath, S., Wong, K.C., Taylor, J., Burnett, E., Gut, I., Farrall, M. et al. (2007) A genome-wide association study of global gene expression. Nat. Genet., 39, 1202-1207.
30. Stranger, B.E., Nica, A.C., Forrest, M.S., Dimas, A., Bird, C.P., Beazley, C., Ingle, C.E., Dunning, M., Flicek, P., Koller, D. et al. (2007) Population genomics of human gene expression. Nat. Genet., 39, 1217-1224.
31. Bassuk, A.G., Barton, K.P., Anandappa, R.T., Lu, M.M. and Leiden, J.M. (1998) Expression pattern of the Ets-related transcription factor Elf-1. Mol. Med., 4, 392-401.
32. Sarafova, S. and Siu, G. (1999) A potential role for Elf-1 in CD4 promoter function. J. Biol. Chem., 274, 16126-16134.
33. Wurster, A.L., Siu, G., Leiden, J.M. and Hedrick, S.M. (1994) Elf-1 binds to a critical element in a second CD4 enhancer. Mol. Cell. Biol., 14, 6452-6463.
34. Ji, H.B., Gupta, A., Okamoto, S., Blum, M.D., Tan, L., Goldring, M.B., Lacy, E., Roy, A.L. and Terhorst, C. (2002) T cell-specific expression of the murine CD3delta promoter. J. Biol. Chem., 277, 47898-47906.
35. Ernst, P., Hahm, K., Trinh, L., Davis, J.N., Roussel, M.F., Turck, C.W. and Smale, S.T. (1996) A potential role for Elf-1 in terminal transferase gene regulation. Mol. Cell. Biol., 16, 6121-6131.
36. Gottschalk, L.R., Giannola, D.M. and Emerson, S.G. (1993) Molecular regulation of the human IL-3 gene: inducible T cell-restricted expression requires intact AP-1 and Elf-1 nuclear protein binding sites. J. Exp. Med., 178, 1681-1692.
37. Wang, C.Y., Bassuk, A.G., Boise, L.H., Thompson, C.B., Bravo, R. and Leiden, J.M. (1994) Activation of the granulocyte-macrophage colonystimulating factor promoter in T cells requires cooperative binding of Elf-1 and AP-1 transcription factors. Mol. Cell. Biol., 14, 1153-1159.
38. Akbarali, Y., Oettgen, P., Boltax, J. and Libermann, T.A. (1996) ELF-1 interacts with and transactivates the IgH enhancer pi site. J. Biol. Chem., 271, 26007-26012.
39. Shi, M.J., Park, S.R., Kim, P.H. and Stavnezer, J. (2001) Roles of Ets proteins, NF-kappa B and nocodazole in regulating induction of transcription of mouse germline Ig alpha RNA by transforming growth factor-beta 1. Int. Immunol., 13, 733-746.
40. Shimokawa, T. and Ra, C. (2003) C/EBP alpha and Ets protein family members regulate the human myeloid IgA Fc receptor (Fc alpha R, CD89) promoter. J. Immunol., 170, 2564-2572.
41. Linker-Israeli, M., Bakke, A.C., Kitridou, R.C., Gendler, S., Gillis, S. and Horwitz, D.A. (1983) Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). J. Immunol., 130, 2651-2655.
42. Chun, H.Y., Chung, J.W., Kim, H.A., Yun, J.M., Jeon, J.Y., Ye, Y.M., Kim, S.H., Park, H.S. and Suh, C.H. (2007) Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus. J. Clin. Immunol., 27, 461-466.
43. Altman, A., Theofilopoulos, A.N., Weiner, R., Katz, D.H. and Dixon, F.J. (1981) Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2. J. Exp. Med., 154, 791-808.
44. Dauphinee, M.J., Kipper, S.B., Wofsy, D. and Talal, N. (1981) Interleukin 2 deficiency is a common feature of autoimmune mice. J. Immunol., 127, 2483-2487.
45. Wofsy, D., Murphy, E.D., Roths, J.B., Dauphinee, M.J., Kipper, S.B. and Talal, N. (1981) Deficient interleukin 2 activity in MRL/Mp and C57BL/6J mice bearing the lpr gene. J. Exp. Med., 154, 1671-1680.
46. John, S., Reeves, R.B., Lin, J.X., Child, R., Leiden, J.M., Thompson, C.B. and Leonard, W.J. (1995) Regulation of cell-type-specific interleukin-2 receptor alpha-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-kappa B family proteins. Mol. Cell. Biol., 15, 1786-1796.
47. Serdobova, I., Pla, M., Reichenbach, P., Sperisen, P., Ghysdael, J., Wilson, A., Freeman, J. and Nabholz, M. (1997) Elf-1 contributes to the function of the complex interleukin (IL)-2-responsive enhancer in the mouse IL-2 receptor alpha gene. J. Exp. Med., 185, 1211-1221.
48. Rusterholz, C., Henrioud, P.C. and Nabholz, M. (1999) Interleukin-2 (IL-2) regulates the accessibility of the IL-2-responsive enhancer in the IL-2 receptor alpha gene to transcription factors. Mol. Cell. Biol., 19, 2681-2689.
49. Crispin, J.C., Liossis, S.N., Kis-Toth, K., Lieberman, L.A., Kyttaris, V.C., Juang, Y.T. and Tsokos, G.C. (2010) Pathogenesis of human systemic lupus erythematosus: recent advances. Trends Mol. Med., 16, 47-57.
50. Rellahan, B.L., Jensen, J.P., Howcroft, T.K., Singer, D.S., Bonvini, E. and Weissman, A.M. (1998) Elf-1 regulates basal expression from the T cell antigen receptor zeta-chain gene promoter. J. Immunol., 160, 2794-2801.
51. Tsokos, G.C., Nambiar, M.P. and Juang, Y.T. (2003) Activation of the Ets transcription factor Elf-1 requires phosphorylation and glycosylation: defective expression of activated Elf-1 is involved in the decreased TCR zeta chain gene expression in patients with systemic lupus erythematosus. Ann. N. Y. Acad. Sci., 987, 240-245.
52. Juang, Y.T., Solomou, E.E., Rellahan, B. and Tsokos, G.C. (2002) Phosphorylation and O-linked glycosylation of Elf-1 leads to its translocation to the nucleus and binding to the promoter of the TCR zeta-chain. J. Immunol., 168, 2865-2871.
53. Juang, Y.T., Sumibcay, L., Tolnay, M., Wang, Y., Kyttaris, V.C. and Tsokos, G.C. (2007) Elf-1 binds to GGAA elements on the FcRgamma promoter and represses its expression. J. Immunol., 179, 4884-4889.
54. Finco, T.S., Justice-Healy, G.E., Patel, S.J. and Hamilton, V.E. (2006) Regulation of the human LAT gene by the Elf-1 transcription factor. BMC Mol. Biol., 7, 4.
55. Hochberg, M.C. (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum., 40, 1725.